Risk Assessment of Trigonelline in Coffee and Coffee By-Products

Risk Assessment of Trigonelline in Coffee and Coffee By-Products Nick Konstantinidis,1,2 Heike Franke,1 Steffen Schwarz,3 and Dirk W. Lachenmeier2,* Jolanta Sereikaitė, Academic Editor Author information Article notes Copyright and License information PMC Disclaimer Associated Data Data Availability Statement Go to: Abstract Trigonelline is a bioactive pyridine alkaloid that occurs naturally in high concentrations in coffee (up to 7.2 g/kg) and coffee by-products (up to 62.6 g/kg) such as coffee leaves, flowers, cherry husks or pulp, parchment, silver skin, and spent grounds. In the past, coffee by-products were mostly considered waste and discarded. In recent years, however, the use of coffee by-products as food has attracted interest because of their economic and nutritional value and the environmental benefits of sustainable resource use. Their authorization as so-called novel foods in the European Union may lead to increased oral exposure of the general population to trigonelline. Therefore, the aim of this review was to assess the risk to human health of acute and chronic exposure to trigonelline from coffee and coffee by-products. An electronic literature search was performed. Current toxicological knowledge is limited, with few human data available and a lack of epidemiological and clinical studies. There was no evidence of adverse effects after acute exposure. No conclusion can be drawn on chronic exposure to isolated trigonelline due to the lack of data. However, trigonelline ingested as a component of coffee and coffee by-products appears to be safe for human health, based on the safe traditional use of these products. Keywords: trigonelline, coffee, coffee by-products, toxicity, human, risk assessment Go to: 1. Introduction Trigonelline (IUPAC: 1-methylpyridin-1-ium-3-carboxylate, C7H7NO2) is a solid, crystallizable pyridine alkaloid that was first isolated from the seeds of fenugreek (Trigonella foenum-graecum L.) by German pharmacist Ernst Friedrich Jahns in 1885 [1,2,3]. It is a small, highly hydrophilic (Table 1), and thermolabile phytochemical [1,2,3,4,5,6,7,8] naturally occurring in numerous plants as a secondary metabolite [9,10,11,12,13]. Particularly high contents up to 34.2 g/kg are found in green coffee beans (family Rubiaceae, genus Coffea) [4,13,14,15,16,17,18,19,20], with trigonelline thus being the most abundant alkaloid in green coffee beans second to caffeine [17]. Apart from plants, trigonelline has been detected in several animals [10,11,21], and is also present in human plasma, serum, and urine [17,22,23,24,25,26]. Table 1 Physicochemical properties of trigonelline [2]. Physicochemical Property Information Molecular weight 137.14 g/mol Octanol–water partition coefficient (log KOW) −2.53 Open in a separate window As discovered in green peas (Pisum sativum L.) by Joshi and Handler in 1960, trigonelline is believed to be synthesized in planta via methylation of the nitrogen atom of nicotinic acid, with S-adenosyl-L-methionine (SAM) serving as methyl donor and SAM:nicotinic acid N-methyltransferase, synonymously N-methyltransferase or trigonelline synthase (EC 2.1.1.7), as catalyzing enzyme (Figure 1) [27,28,29]. In 2014, the genes of this enzyme were successfully isolated from beans of Coffea arabica L. [30], suggesting a similar biosynthetic pathway in coffee plants. In these, trigonelline is formed in all tissues (yet, primarily in the fruits (Figure 2)), with higher outputs in younger than in older tissues [9,31,32]. A detailed overview of the biosynthesis in plants is provided by Ashihara et al. [29]. In animals and humans, biosynthesis is still unknown, but may happen analogously via methylation of nicotinic acid [26]. An external file that holds a picture, illustration, etc. Object name is molecules-28-03460-g001.jpg Figure 1 Biosynthesis of trigonelline in plants upon methylation of nicotinic acid via SAM:nicotinic acid N-methyltransferase (SAM, S-adenosyl-L-methionine. SAH, S-adenosyl-L-homocysteine) [27,28,29]. An external file that holds a picture, illustration, etc. Object name is molecules-28-03460-g002.jpg Figure 2 Coffee fruits in different stages of ripeness. Various functions of trigonelline in planta have been proposed, such as serving as a nutrient source and compatible solute, involvement in cell cycle regulation by arresting the G2 phase, signal transduction, nyctinasty (orientation of a plant’s leaves, flowers, cotyledons, or branches toward the light source to maximize photosynthesis [33]), and nodulation (symbiotic relationship of capable plants with certain bacteria (rhizobia), leading to the formation of specific root structures (nodules) to enable nitrogen fixation [34]) [29,35,36]. The most plausible role may be detoxification of nicotinic acid, which, in excess concentrations, is detrimental to plants [9,13,36,37]. No physiological functions in animals and humans are known [12,38]. However, trigonelline provides nutritional value as it decomposes back to its precursor nicotinic acid (niacin or vitamin B3) in coffee beans upon exposure to roasting temperatures (see Section 5) [17,39,40,41]. Furthermore, multiple possible health-promoting effects in humans are documented. These include antimicrobial and anticariogenic [42], antioxidative [43,44,45], antilipidemic [43,46,47], hypocholesterolemic [43], and hypoglycemic effects [46,48,49,50]. Recently, trigonelline was also shown to protect against the formation of kidney stones [51]. The possible health-promoting effects exhibited by trigonelline have been reviewed elsewhere [12,52]. The most important source of trigonelline commercially available is coffee [29]. Originating from the Kaffa highlands of Ethiopia, where coffee is believed to have been cultivated and produced intentionally for the first time in the 15th century, coffee spread to Europe quickly during the 17th century [53] and has become one of the most consumed beverages and thus traded commodities worldwide due to its flavor and psychostimulating properties [54,55]. As shown in Figure 3, except for two years of negative fluctuation (2019/20 and 2020/21), global consumption has been steadily growing over the last ten years (by 17.6% from 2012/13 to 2021/22) [56,57,58] and is forecasted to further grow [56,59]. An external file that holds a picture, illustration, etc. Object name is molecules-28-03460-g003.jpg Figure 3 Global domestic coffee consumption from 2012/13 to 2021/22 in million 60 kg bags [56,57,58]. Of the approximately 100 species of the genus Coffea, C. arabica and C. canephora Pierre ex A. Froehner are mainly used for coffee production and are therefore the most economically valuable [15,59]. Together, these two species contribute to ca. 99% of global coffee production [59,60]. After cultivation, the cherry-like coffee fruits, hence alternatively named coffee cherries, are usually harvested by hand-picking [39,54,61]. Once harvested, the coffee fruits are processed via a dry or wet method [61,62] and converted to green coffee beans. These are then roasted, ground, and after preparation with hot (or lately also cold) water, consumed as the commonly known coffee brew or beverage [39,54,61]. Besides green coffee beans, the economically most important coffee plant organ [63], several by-products accrue during cultivation and production [64,65]. For food production, the most promising of these by-products are coffee leaves, flowers, cherry husks or pulp (also known as cascara), parchment (the endocarp of the coffee fruit), silver skin (a thin tegument, also referred to as testa or epidermis, covering the coffee beans), and spent grounds (the residue or mass left after coffee brewing) [62]. Yet, coffee by-products are either, if at all, used as natural fertilizers or, in many cases, considered waste and discarded. However, since sustainable food production is of growing ecological importance, utilizing these by-products more efficiently appears highly advisable [65,66]. In fact, as concluded at the 2nd International Electronic Conference on Foods discussing coffee by-products as sustainable foods, they offer significant economic value [64]. Moreover, being rich in carbohydrates and/or fibers, proteins, and antioxidants, nutritional value has been attributed to them [67,68,69,70,71]. Therefore, dietary use as food may constitute an economically and nutritionally beneficial option [64]. Indeed, within the European Union (EU), several coffee by-products are currently undergoing approval procedures or have already been approved to be introduced to the EU market as so-called novel foods or traditional foods from a third country under Regulation (EU) 2015/2283 by the EU Commission. For detailed information on this, see [62,64,65]. The official definitions of novel food and traditional food from a third country can be found here [72]. Note, all authorized novel foods are listed in the annex of the Regulation (EU) 2017/2470, in the permanently updated Union List of Novel Foods [73]. Importantly, all of the above coffee by-products contain trigonelline, with levels varying from 0.40 to 62.6 g/kg (see Section 3). The authorization of coffee by-products to be marketed as food in the EU will therefore introduce additional dietary sources of trigonelline. This may lead to increased oral exposure of the general population in the EU. The aim of this review was therefore to assess the risk to human health from acute and chronic oral exposure to trigonelline from coffee and coffee by-products. Go to: 2. Literature Research For this purpose, the electronic databases Google Scholar and PubMed were searched for available literature on trigonelline in coffee and coffee by-products. The strategy of the literature search consisted of three steps. To characterize trigonelline and its pharmacokinetics in humans, in the first step, it was specifically searched for original articles providing information on the biosynthesis, absorption, bioavailability, distribution, metabolism, elimination, and/or excretion of trigonelline in humans. This step also included gathering nutritional information on trigonelline and data to provide a brief background on coffee and coffee by-products. In the second step, the databases were searched for original articles on in vitro, in vivo, and/or human data on toxicological endpoints. For the risk assessment of acute and chronic exposure, a realistic worst-case scenario was assumed, estimating the maximum amount of trigonelline theoretically ingested from coffee and coffee by-products per day. For this, information on the trigonelline content and daily consumption of the respective matrices was collected in the third step of the literature search. The search terms used included, amongst others, trigonelline, 1-methylpyridin-1-ium-3-carboxylate, coffee, coffee by-products, toxicity, adverse effects, exposure, and human. Only materials of C. arabica and C. canephora origin were included, as these are the economically and dietary most important coffee species in the EU [59]. Other species were excluded as they are of minor economic and dietary importance [60] and usually contain considerably lower trigonelline concentrations [74]. Studies not indicating the coffee species investigated were likewise excluded. All retrieved articles or hits deemed suitable for this work, based on the information provided in their abstracts, were entered into a bibliographic management software, and subsequently processed in detail individually (n = 190). As the literature search revealed a shortage of data, suitable articles were considered regardless of their publication date. Only studies accessible in the full text were used for this review. Go to: 3. Estimation of Human Oral Exposure 3.1. Trigonelline Contents of Coffee and Coffee By-Products Data on the trigonelline contents are comparatively scarce. For coffee silver skin and spent grounds, only one study was found, with Wang et al. reporting to be the first to detect trigonelline in coffee silver skin [75]. Table 2 lists the trigonelline contents as reported by the accessible studies meeting the inclusion criteria outlined in Section 2. For easier comparison, the original values were additionally converted to g/kg. Table 2 Trigonelline contents of coffee and coffee by-products of C. arabica and C. canephora origin. Matrix Trigonelline Content Coffee Species Reference Converted Trigonelline Content (g/kg) Leaves 2.955–11.718 mg/g DW A [76] 3.0–11.7 3.93–6.84 mg/g A [77] 3.9–6.8 4.47 ± 0.13 g/kg DW A [78] 4.5 8.2–28.3 µmol/g FW A [18] 1.1–3.9 4.157–7.879 mg/g DW R [76] 4.2–7.9 4.2–6.0 mg/g DW R [79] 4.2–6.0 Range 1.1–11.7 (min–max) Flowers 378.1–5278.6 mg/100 g DW A [44] 3.8–52.8 429.1–6258.3 mg/100 g DW R [44] 4.3–62.6 1092.8 mg/100 g DW R [80] 10.9 755–1965 mg/100 g A, R [81] 7.6–19.7 Range 3.8–62.6 (min–max) Cherry Husks/Pulp 285.58–542.8 mg/100 g DW 1 A [6] 2.9–5.4 1 550.45–558.02 mg/kg DW A [82] 0.6–0.6 Range 0.6–5.4 (min–max) Parchment 2 1.24–1.36% DW A [83] 12.4–13.6 120.16–246.21 mg/100 g DW 2 A [6] 1.2–2.5 2 Range 1.2–13.6 (min–max) Green coffee beans 1.52–2.9 g/100 g DW A [4] 15.2–29.0 8.8–27.6 mg/g DW A [79] 8.8–27.6 0.88–1.77% DW A [16] 8.8–17.7 9.1–15.9 g/kg A [20] 9.1–15.9 16.8–71.2 µmol/g A [18] 2.3–9.8 55.67 µmol/g FW A [17] 7.6 52.5 ± 0.8 µmol/g FW A [13] 7.2 0.98–1.32% w/w DW A [84] 9.8–13.2 547–991 mg/100 g A [14] 5.5–9.9 7.5–34.2 mg/g DW R [79] 7.5–34.2 3.08 g/100 g DW R [4] 30.8 0.75–1.24% DW R [16] 7.5–12.4 7.5–12.0 g/kg R [20] 7.5–12.0 Range 2.3–34.2 (min–max) Roasted coffee beans 5.25–7.48 g/kg DW A [85] 5.3–7.5 3.69–4.81 mg/g A [14] 3.7–4.8 41.82 ± 2.1 µmol/g FW A [17] 5.7 3.08–5.54 g/kg DW R [85] 3.1–5.5 Range 3.1–7.5 (min–max) Silver skin 3.65% DW A [75] 36.5 36.5 Coffee beverages 1.9–7.2 mg/mL A [86] 1.9–7.2 50.74–72.70 mg/25 mL (espresso) A [87] 2.0–2.9 0.19–0.33 mg/mL A [88] 0.2–0.3 2310 nmol/mL A [26] 0.3 21.99–49.44 mg/25 mL (espresso) R [87] 0.9–2.0 Range 0.2–7.2 (min–max) Spent coffee grounds 0.4–2.4 mg/mL A [86] 0.4–2.4 Range 0.4–2.4 (min–max) Open in a separate window 1 Samples comprised 80% husks and pulp and 20% parchment. 2 Samples comprised 28% husks and pulp and 72% parchment. A, C. arabica. R, C. canephora. FW, fresh weight. DW, dry weight. If neither FW nor DW is indicated, the referenced study does not provide this information. As shown, the trigonelline contents vary greatly from 0.2 to 63 g/kg (factor ~200) depending on multiple factors, for instance: country of origin [89], coffee species and cultivar [74,90], part of the coffee plant [9], age of the plant part [19,76,77,79], applied industrial production processes [6,91,92], used preparation methods [93,94], water content of the sample [84], pH condition of the sample media [95], and analytical method used [95]. Due to the distinct water solubility and thermolability of trigonelline, concentrations in green coffee beans were shown to be markedly reduced during industrial (a) washing and blanching, leading to losses via leaching [6], and (b) roasting and steaming, causing losses via thermally induced decomposition [14,40,96]. Consequently, profoundly lower concentrations were found in roasted than in green (i.e., unroasted) coffee beans. Numerous studies have demonstrated that both water- and heat-induced reduction depend on the time-temperature profile applied, with 15–90% of trigonelline being degraded with increasing processing time and/or temperature [6,17,40,95,97,98,99]. Fast roasting is therefore associated with higher trigonelline contents than slower roasting approaches [74]. Furthermore, decaffeination was shown to lower the trigonelline content of coffee beverages by up to 17.1% [74,96,98]. Besides industrial processes, the characteristics of the method used for preparing the final beverage have proven to be a crucial factor. For instance, Ziefuß et al. revealed that hot-brew coffee variants contain noticeably less trigonelline than their cold-brewed counterparts [93]. When espresso coffees were prepared from C. arabica and C. canephora blends using a regular espresso machine set at 92 °C and 9 bar, the trigonelline content fell by 92.3% from the shortest (0–10 s) to the longest extraction time (36–40 s) [87]. Considering these trigonelline-reducing influences, it is not surprising that the lowest concentrations are observed in coffee beverages and the remaining spent grounds. According to Wu et al., coffee beverages from C. canephora usually contain about one-third less trigonelline than those from C. arabica [90], which concurs with the findings of Jeszka-Skowron and colleagues [96]. The highest trigonelline content was interestingly reported to be present in coffee flowers [44]. Contrarily, according to other authors, the trigonelline content of coffee flowers does not exceed 20 g/kg [80,81], thus being about three times lower than reported by Abreu Pinheiro et al. [44]. This discrepancy may be partially explained by the different analytical methods used and the age of the flowers analyzed. As described by Monteiro et al., the trigonelline content of coffee flowers correlates inversely with the flower’s age and decreases by up to 24.1% accordingly [76]. This correlation has also been observed in coffee leaves, with contents naturally declining as the leaf matures and senesces [18,79]. 3.2. Theoretical Maximum Daily Intake of Trigonelline In order to estimate the oral exposure of the EU general population to trigonelline from coffee beverages, knowledge of the daily consumption of coffee beverages and the mass of ground, roasted coffee beans weighed-in per volume of water is necessary. Yet, most sources use the term “cup of coffee” without specifying the amount of ground beans used in the preparation of the final drink. Thus, according to Romualdo et al., the most reliable data are represented by estimates of the annual consumption of ground beans per capita (which are typically expressed in kilograms) [55]. However, from such data, actual consumption habits regarding daily intake of coffee beverages can only be vaguely derived. Thus, data on the daily consumption of coffee beverages in the EU were adopted from the comprehensive European Food Consumption Database of the European Food Safety Authority (EFSA), as published in the 2018 International Agency for Research on Cancer (IARC) monograph, Drinking Coffee, Mate, and Very Hot Beverages [100], selecting the highest estimate reported. Accordingly, a daily maximum of 1914 mL of coffee was drunk per capita in Denmark (sex and year unspecified) [100]. No data on the daily consumption of coffee by-products per capita in the EU were available. Therefore, a realistic worst-case scenario was assumed. As reviewed by Klingel et al., coffee leaves, flowers, cherry husks or pulp, green coffee beans, and silver skin may be used to make tea [62]. Recently, an infusion of coffee leaves from C. arabica and/or C. canephora has been authorized for marketing by the EU Commission under Regulation (EU) 2015/2283 [72,101]. Thus, the consumption of coffee by-products as tea infusion was viewed as a realistic scenario. Within this scenario, the following assumptions were made: For the preparation of one serving, 2 g of the respective coffee by-product and 200 mL of cold water are used. Except for the cold water, this is in concordance with the procedure described by Steger et al., who used hot water [94]. In this scenario, cold water is used because hot water may induce thermal degradation of trigonelline, thus lowering the possible amount that could be ingested (see Section 3.1). Further, since trigonelline is highly soluble in water (see Section 1), a complete extraction into the tea infusion was assumed to occur. Data on daily consumption of tea infusions were obtained from the German National Consumption Study II (Nationale Verzehrsstudie II). This is the largest epidemiological study conducted in Germany to collect representative information on the dietary habits and food consumption of the German general population. The study was coordinated by the Max Rubner-Institut (MRI) and conducted from 2005 to 2007. Using computer-assisted personal interviews, diet history interviews covering the last four weeks, written questionnaires, and 24 h dietary recalls, data from 19,329 participants (thereof, 8923 males and 10,406 females) aged 14–80 years were collected [102]. Different foods were considered and divided into certain main groups and subgroups, with tea infusions assigned to the main group “alcohol-free beverages” and the two subgroups (a) “coffee and green/black tea” and (b) “herbal/fruity tea”. Here, subgroup (a) was excluded since the proportions between coffee and green/black tea are not specified, making a reasonable estimate impossible. Thus, subgroup (b) was considered solely. Accordingly, a maximum (95th percentile) of 1300 g of herbal and/or fruity tea was consumed by females daily; males drank a maximum of 800 g per day [103]. In the sense of the worst-case scenario outlined, the amount consumed by females was considered. For the purpose of the present work, it is assumed that 1300 g is equivalent to 1300 mL. Note, for coffee parchment (possible use in food preservatives or antioxidants [62]) and spent grounds (possible use in bakery products [62]), an exposure estimate is not feasible due to lacking data on the proportion to which parchments and spent grounds might be used in certain foods. Roasted coffee beans are assumed to be utilized exclusively for making coffee beverages, as is typically the case in the EU [93]. Therefore, a separate estimation was not performed. Table 3 shows the results of this exposure estimation. Table 3 Theoretical maximum daily intake of trigonelline via coffee and coffee by-products. Matrix Trigonelline Content per Serving (g/200 mL) 1 Consumption of Tea Infusions or Coffee Beverages (mL/day) Theoretical Maximum Daily Intake (g/day) Leaves 0.023 1300 0.152 Flowers 0.125 1300 0.814 Cherry Husks/Pulp 0.011 1300 0.070 Green coffee beans 0.068 1300 0.445 Silver skin 0.073 1300 0.475 Coffee beverages 1.44 1914 13.8 Open in a separate window 1 For coffee by-products, a preparation of tea infusions with 2 g of coffee by-product per 200 mL of cold water was assumed. For further explanation, see text. For coffee beverages, the assumption of weighing-in 2 g of, in this case, ground, roasted coffee beans, was not made as data for the final beverage are available (see Table 2). To account for the outlined worst-case scenario, for each matrix the highest trigonelline content as reported in Table 2 was used in the calculations. By far, the highest theoretical maximum daily intake of trigonelline results from coffee beverages. The theoretical amount ingested via coffee by-products is significantly lower (factor 17–194) and is negligible in relation to coffee beverages. Go to: 4. Absorption, Distribution, Metabolism, and Excretion The pharmacokinetics of trigonelline have repeatedly been studied in humans [17,22,23,24,25,26,92,104,105,106,107,108]. Accordingly, absorption and oral ingestion are strongly correlated [22,23,24,26,105,107,108]. Since plasma concentrations responded rapidly as early as 15 min after administration, absorption is proposed to start in the stomach [26,92]. Peak plasma concentrations were reached at 3.00–8.48 h after administration [92,108], suggesting trigonelline to be predominantly absorbed in the small intestine [92]. No data on oral bioavailability in humans are available. In pathogen-free Sprague–Dawley rats, however, the absolute bioavailability of trigonelline administered orally via a methanol extract of coffee beans amounted to 64.42% [109]. In humans, differences in plasma concentrations between the sexes have been observed. Whilst Lang et al. found no differences in plasma concentrations between male and female participants within the first 2–4 h after ingestion, sex-dependent differences were observed in later phases, as peak plasma concentrations of females were 16.3% higher and reached considerably later (females: 3.17 h, males: 2.29 h) [26]. Coinciding with these results, Bresciani and colleagues found significantly higher Cmin, Cavg, Cmax, and AUC0–24 in females in relation to males [108]. These intersexual differences may be attributable to the lower body mass and blood volume of the recruited females, resulting in less dilution of trigonelline in the blood [26,108]. Further, plasma trigonelline was shown to be 20% lower in fasting than in non-fasting participants and increased by 9% per decade of age [107]. It is unclear whether smoking affects plasma levels. While it has been described that plasma concentrations of former and current smokers were 24 and 48% higher, respectively, than those of participants who had self-reportedly never smoked in their life [107], another study showed no statistically significant effect of smoking [108]. The volume of distribution (Vd), calculated on the basis of data from 13 volunteers, was described as comparatively small at 123 L [26] (for context: Holford and Yim [110] define the Vd as very small at 10 L and large at 500 L), suggesting that trigonelline remains primarily in the blood [17,22,23,26]. Yet, in transgenic mice, trigonelline entered the cerebral cortex [111], implying the ability of this compound to cross the blood-brain barrier. Little is known about its metabolism in humans. Upon oral administration, four potential methylation and oxidation products were detected in plasma and urine: N-methylpyridinium, N-methylnicotinamide, N1-methyl-4-pyridone-5-carboxamide, and N1-methyl-2-pyridone-5-carboxylic acid [105,108,112]. Moreover, trigonelline may be transformed to further pyridinium compounds via ring fission [105]. Up to 64.3% of the ingested amount is excreted unchanged via the urine within the first 8 h after ingestion [26,92,105], and additionally, about 10% as N1-methyl-2-pyridone-5-carboxylic acid [105], leaving the fate of the remaining ~30% unclear. Considering the good water solubility of trigonelline, it is likely that the vast majority of this proportion may also be excreted via the urine at later stages without undergoing any prior chemical changes [17,105]. As with absorption, excretion and oral ingestion are positively correlated [17,22,23,24,25,26,105,106,108]. It is noteworthy that trigonelline accumulated in human plasma at markedly elevated levels for an extended period of time following repeated ingestion of coffee beverages [26,92], due to the long biological elimination half-life of around 5.5 h [92,108]. Thus, plasma elimination and subsequent renal excretion occur relatively slowly [26,92]. Therefore, complete clearance of plasma trigonelline is unlikely in humans who habitually consume coffee several times a day [92]. Yet, plasma concentrations decreased back to baseline levels when coffee consumption was discontinued [108]. Go to: 5. Nutritional Information Trigonelline, as a constituent of green coffee beans, decomposes readily when heated at roasting temperatures above 180 °C [14], giving rise to various volatile derivatives such as pyrroles, alkylpyridines, and phenolic compounds, thereby influencing the flavor and aroma of coffee products. Additionally, nicotinic acid is produced as one of two non-volatile derivatives following N-demethylation (the second being N-methylpyridinium as a decarboxylation product) [17,39,92]. Serving as a precursor for essential nicotinic acid (niacin or vitamin B3) in coffee beans, trigonelline thus has nutritional value [8,17,39]. However, it is unclear whether intact trigonelline ingested via foods is metabolized to nicotinic acid in the human body and thus acts as a provitamin. Metabolic transformation to nicotinic acid is only assumed to potentially occur [26]. The German Nutrition Society (DGE) recommends a daily intake of 16 mg of niacin for male adults aged 19–24 years [113]. According to Caprioli et al., espresso coffee from C. canephora contains up to 10.3 mg of niacin per serving (25 mL) [87]. Thus, a single serving of espresso coffee could contribute to roughly 64% of the recommended daily intake of niacin. Yet, no significant increase in plasma niacin levels was observed in six female and seven male healthy volunteers following a bolus dose of 350 mL of coffee beverages from C. arabica ingested within 5 min [26]. To answer the question of whether trigonelline contributes considerably to the recommended daily intake of niacin further studies are needed. Go to: 6. Toxicological Information Historically, trigonelline has been investigated focusing on beneficial effects on human health. Studies examining toxic or adverse effects are scarce and mostly date back many years to several decades. Toxicological studies have primarily been performed using cell cultures or laboratory animals. Thus, few human data exist. 6.1. Acute Toxicity Trigonelline did not exert any cytotoxic effects in concentrations up to 100 µmol/L in human neuroblastoma SK-N-SH cells [114], human hepatocellular carcinoma (Hep3B) cells [115], human immortalized dermal keratinocytes (HaCat) and human foreskin fibroblasts (Hs68) [45] after treatment for six days, 48 and 24 h, respectively. In fact, in a recent study, trigonelline protected UV-B radiation-exposed Hs68 cells against photodamage by restoring the physiological function of the endoplasmic reticulum, decreasing oxidative stress, and positively modulating calcium homeostasis and apoptosis in a dose-responsive manner (10, 25, 50, and 100 µmol/L) [45]. It also did not alter the morphology of Madin–Darby bovine kidney cells and African green monkey kidney cells (Vero cells) at concentrations of 1.6 µg/mL each after 48 h of exposure [42]. In an animal study from 1946, the first of its kind to examine the acute effects of trigonelline according to the literature search, Brazda and Coulson administered trigonelline subcutaneously to rats (strain and sex not provided). As a result, a dose of 5000 mg/kg body weight (bw) was found to be lethal (LD50) [116]. This observation has been corroborated twice: first, by Mishkinsky et al., who determined the same LD50 after oral administration to female albino Sabra rats [117]; and second, by Aswar et al., who did not notice alteration of behavior or increased mortality in mice (strain and sex not provided) after administration of doses up to 5000 mg/kg bw via unspecified route [118]. No papers reporting other LD50 values were found. Additionally, no human data on acute toxicity were uncovered. As no data from human studies are available, the acute toxicity of isolated trigonelline was predicted in silico, among other toxicological endpoints (see Section 6.2, Section 6.3 and Section 6.4), using the freely available computational platform ProTox-II [119]. With a moderate prediction accuracy of 69.26%, the results for the acute oral toxicity of trigonelline were negative. The methods used in the in silico predictions are described in detail in the Model Info section of the ProTox-II platform. Additionally, a short description of this tool is provided here [120]. 6.2. Subchronic Toxicity Three animal studies were identified with designs appropriate for the investigation of subchronic toxicity. In cats (strain and sex not provided), trigonelline administered at doses up to 3500 mg/kg bw for 62–70 days did not induce any visible effects [121]. Additionally, when albino Sabra rats were fed 50 mg/kg bw of trigonelline daily for 21 days and sacrificed after 42 days, no changes in the weight of the thyroid, thymus, kidneys, liver, adrenals, ovaries, and uterus were observed [117]. In a more recent study from 2014, Folwarczna et al. exposed ovariectomized (i.e., estrogen-deficient) and non-ovariectomized, three-month-old female Wistar rats orally to 50 mg/kg bw of trigonelline daily for 28 days. No adverse effects were noticed in the non-ovariectomized rats. In contrast, a significantly increased weight of the uterus and L4 vertebra was observed in the ovariectomized, estrogen-deficient rats. Estrogen deficiency led to the onset of osteoporotic changes of the skeleton. Oral administration of trigonelline aggravated these skeletal changes by worsening the mechanical properties and mineralization of cancellous bones. The mechanism by which these adverse effects were produced is unknown [122]. No reports on subchronic effects in humans have been published. However, the results of the in silico predictions performed using ProTox-II did not suggest any signs of subchronic toxicity of isolated trigonelline [119]. 6.3. Genotoxicity and Mutagenicity The first in vitro experiments on the potential mutagenicity of trigonelline were conducted by Fung et al. in 1988. The authors showed that pure trigonelline did not produce any mutagenic activity in an L5178Y TK+/− mouse lymphoma assay and several Salmonella typhimurium test systems (i.e., Ames tests) [10]. Contrarily, in the S. typhimurium assays conducted by Wu and colleagues, heated trigonelline, applied to the plates (a) alone and (b) combined with certain amino acids caused substantial amounts of revertants, especially when in binary combination with serine (12,740 revertants/mmol) or threonine (11,270/mmol). Of all the 13 single compounds examined in that study in strain TA98, heated trigonelline applied to the plates alone produced the most revertants (8160/mmol) and exhibited the highest mutagenicity [7]. Table 4 summarizes the results of these studies. Table 4 Results for trigonelline in different genotoxicity and mutagenicity test systems. Test System Strains Metabolic Activation Dose of Trigonelline Result Ref. L5178Y TK+/− mouse lymphoma assay - With and without 0.5 mL of S9 from Aroclor-1254-induced male Fischer 344 rats Up to 7429 µg/mL Negative [10] S. typhimurium assay TA1535 TA1537 TA1538 TA98 TA100 With and without 0.5 mL of S9 from Aroclor-1254-induced male Fischer 344 rats and Syrian golden hamsters Up to 10,000 µg/plate Negative S. typhimurium assay TA98 With 0.5 mL of S9 from chlorophene-induced rat liver 1000 µmol Positive [7] Plus 1000 µmol of a single amino acid: Alanine Positive Arginine Positive Cysteine Positive Cystine Negative Lysine Positive Phenylalanine Positive Proline Positive Serine Positive Threonine Positive Tryptophan Negative Valine Positive Plus 200,000 µmol/L of glucose Positive S. typhimurium assay TA98 With 0.5 mL of S9 from chlorophene-induced rat liver Mix I 1 Positive [7] Mix II 2 Positive Without 0.5 mL of S9 from chlorophene-induced rat liver Mix I Positive Mix II Positive YG1024 With 0.5 mL of S9 from chlorophene-induced rat liver Mix I Positive Mix II Positive Without 0.5 mL of S9 from chlorophene-induced rat liver Mix I Toxic Mix II Toxic YG1029 With 0.5 mL of S9 from chlorophene-induced rat liver Mix I Negative Mix II Negative Without 0.5 mL of S9 from chlorophene-induced rat liver Mix I Positive Mix II Positive Open in a separate window 1 Mix I consisted of 1000 µmol trigonelline, 100 µmol glucose, and a mixture of alanine, arginine, aspartic acid, asparagine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, phenylalanine, proline, serine, threonine, tyrosine, valine, and tryptophan. 2 Mix II consisted of 1000 µmol trigonelline, 100 µmol glucose, and a mixture of aspartic acid, asparagine, and glutamic acid. The molar percentages of the amino acids are indicated in the original paper [7]. For simplicity, details on the respective test procedures are not shown, but can be read in the referenced studies. The approaches of the S. typhimurium assays in both studies differed strongly (different strains, metabolic activation, and doses (see Table 4)); thus, comparing the results is hardly possible. A major difference is that, in contrast to Fung and colleagues, Wu et al. mimicked the roasting process of green coffee beans by heating the samples at 250 °C for 20 min during sample preparation, analyzing trigonelline in an approach that more realistically simulates common exposure scenarios, since green coffee beans are not known to be consumed raw in the EU [62]. Before analysis, samples were given time to settle to room temperature. As discussed by Wu et al., the heating of trigonelline may have led to the formation of free radicals and compounds involved or entirely responsible for the mutagenic effects observed. Thus, the production of revertants could not be ascribed to trigonelline unambiguously [7]. Since only these two studies were found and their results are equivocal, further efforts are needed to conclude whether trigonelline is genotoxic and/or mutagenic. However, in the in silico toxicity model computations performed in the present work, trigonelline was predicted not to be mutagenic (p = 0.94) [119]. 6.4. Carcinogenicity Trigonelline has been examined for its potential role in cancer in several in vitro experiments. In only one study was it shown to have effects that could increase the risk of tumor formation, as it significantly induced the proliferation of MCF-7 breast cancer cells in a dose-responsive manner. Noticeably increased total cell numbers were observed at considerably low concentrations of 10 pmol/L, with the most potent proliferative effect yielded at 100 pmol/L. The growth-promoting effect was due to trigonelline binding the estrogen receptors (ER) of the MCF-7 cells in a way similar to estradiol, thereby altering ER-mediated transcription. As discussed by the authors, trigonelline has no structural similarity to estradiol or phytoestrogens. Thus, the authors suggested that trigonelline did not bind the active ligand binding site of the ER, but probably another domain, changing the receptors’ conformation and enabling binding of unspecified transcriptional co-regulators. Hence, trigonelline exerted sound estrogenic activity [123]. This is a significant finding as increased estrogenic activity—either induced by pathological overexpression of ER or mediated by estrogen-like compounds encountered, for instance, via the diet—has been shown to be an important factor in some types of cancer (e.g., breast, colorectal, endometrial, and ovarian cancer [124]), as it stimulates cell growth and proliferation, promoting cancer initiation [125]. In contrast, trigonelline did not yield estrogenic activity in female Wister rats (see Section 6.5) [118], suggesting no trigonelline-induced estrogen-related carcinogenicity in vivo. Moreover, in the in silico carcinogenicity models computed in this work, no carcinogenic effects of trigonelline were predicted (p = 0.66) [119]. Conversely, several in vitro studies have interestingly demonstrated anticarcinogenic effects instead [115,126,127,128,129]. According to Hirakawa and colleagues, trigonelline inhibited the reactive oxygen species (ROS)-potentiated invasion of pretreated AH109A rat ascites hepatoma cells at comparatively much higher concentrations of 2.5–40 µmol/L by means of scavenging ROS [127]. Anticarcinogenic effects were also exerted by significantly inhibiting the migration of Hep3B cells at 100 µmol/L. The cell migration was hampered by a complex cascade of effects. Briefly, trigonelline decreased the phosphorylation of the nuclear factor E2-related factor-2 (Nrf2), a key transcription factor in the gene expression of several antioxidative and xenobiotic-detoxifying enzymes, at serine-40, downregulating its activity and thus the expression of catalase, glutathione peroxidase, and superoxide dismutase [115,128,129]. Consequently, cancer cell survival was possibly decreased by the impaired response to oxidative stress [130], hampering the migration of cancerous cells. Trigonelline also inhibited the gene expression of zinc-dependent matrix metalloproteinase-7 (MMP-7) [115], an endopeptidase that degrades extracellular matrix, reduces cancer cell adhesion, and inhibits apoptosis, thereby suppressing tumor migration and progression [131,132]. Furthermore, trigonelline-mediated inhibition of MMP-7 led to downregulation of the Raf/ERK/Nrf2 signaling pathway, which is believed to play a crucial role in many mechanisms associated with the pathogenesis of various types of cancer [115]. Furthermore, 24 h exposure to 100 µmol/L of trigonelline slightly downregulated the expression of K-RAS, an important proto-oncogene in the progression of colorectal carcinoma, in caco-2 human colon carcinoma cells treated with coffee extracts from C. arabica [133]. Sharma et al. showed that trigonelline (50 µmol/L) reduced the expression of peroxisome proliferator-activated receptor-γ and sterol regulatory element-binding protein-1 in palmitic acid-induced fatty liver disease model human hepatoma (HepG2) cells, suggesting that trigonelline protects against the development of hepatocellular carcinoma by decreasing fatty-acid-mediated lipotoxicity [134]. In total, the above data suggest rather anticarcinogenic effects for trigonelline, mainly by means of positively modulating gene expression. To fully elucidate its role in cancer, appropriate longitudinal in vivo studies are necessary. Yet, such studies are highly resource-consuming and have not been conducted to date. Additionally, while no epidemiological studies are available on trigonelline as an isolated compound, there are ample studies available on coffee consumption, in which trigonelline is one of the major constituents. In a major review of the evidence on coffee, the IARC suggested that there is inadequate evidence in humans for the carcinogenicity of drinking coffee. There is evidence suggesting a lack of carcinogenicity of drinking coffee in humans for cancers of the pancreas, liver, female breast, uterine endometrium, and prostate. Inverse associations with drinking coffee have been observed with cancers of the liver and uterine endometrium [100]. Hence, it may be questionable whether the current evidence would justify the time and resources needed to further study the long-term effects of trigonelline regarding carcinogenicity. 6.5. Reproductive Toxicity and Teratogenic Effects Except for one in vivo study from 2009, no data on reproductive toxicity or teratogenic effects are available. In that study, Aswar et al. aimed to investigate the effects of trigonelline on the estrous cycle and fertility of female Wistar rats. To examine effects on the estrous cycle (endpoint: vaginal cornification), the authors administered doses of 75 mg/kg bw of trigonelline orally to ovariectomized, immature female Wister rats weighing 55–60 g twice on the first two days and once on the third and fourth day of the treatment. Afterwards, vaginal smears were collected and microscopically searched for cornified or nucleated epithelial cells. As no such cells were noticed, it was concluded that trigonelline did not exert estrogenic activity. The same dose was fed daily for seven days to non-ovariectomized, pregnant female Wistar rats (150–200 g bw) to investigate abortifacient activity. No significant differences in the number of implants and litters were observed between treated and control animals. Litters survived and experienced normal growth. Thus, trigonelline did not exhibit abortifacient activity [118]. 6.6. Neurotoxicity Over 50 years ago, Gill et al. investigated trigonelline in a tincture of Cannabis sativum L. and concluded that its neurological agonistic activity is approximately 105 times lower than that of the physiological neurotransmitter acetylcholine. No neurotoxic effects were observed in that in vitro study [135]. Half a century later, current knowledge is still consistent with these findings, as trigonelline has not been shown to exhibit adverse effects on the nervous system in any of the test systems used. Instead, several studies have demonstrated neuroprotective properties [111,114,136,137,138,139,140,141,142,143]. These have been reviewed in detail elsewhere in 2021 [52]. In brief, doses up to 10 µmol/L ameliorated the atrophy of neuronal dendrites and axons in amyloid β-peptide-treated female, hemizygous transgenic 5XFAD Alzheimer’s disease mice model [111]. Additionally, trigonelline (30 µmol/L) improved functional neurite outgrowth in human neuroblastoma SK-N-SH cells after treatment for six days [114,141]. Furthermore, daily oral administration of 500 mg/kg bw for 15 days was demonstrated to improve memory retention in six-week-old amyloid β-peptide-treated male ddY mice [136]. Thus, trigonelline is believed to improve cognition in Alzheimer’s disease model laboratory animals [141,142]. Furthermore, it has been discussed that trigonelline may protect against cerebral ischemia [140] by positively modulating neuronal spike frequency [143], stimulating the release of dopamine [139], competitively inhibiting γ-aminobutyric acid (GABA) A-receptors [138], and weakly hampering acetylcholine esterase [137]. Yet, due to the lack of clinical reports and epidemiological studies, it is impossible to conclude on potential protective effects against neurological diseases in humans. 6.7. Immunotoxicity and Allergenicity No allergenic properties of trigonelline have been reported. In fact, when six-week-old female BALB/c mice were topically exposed to concentrations up to 200 µmol/L on repeated days during a 16-week in vivo treatment, no signs of allergic reactions were noted in the daily physical examinations of the animals [45]. Additionally, an aqueous solution of powdered dried coffee husks from C. arabica, which has been shown to contain rather low levels of trigonelline (see Table 2), did not induce any allergic reactions in skin-prick tests performed on 40 human individuals [144]. In contrast, trigonelline has interestingly been shown to protect against allergic reactions in RBL-2H3 cells and six-week-old female BALB/c model mice. In both experiments, trigonelline suppressed antigen-stimulated mast cell degranulation in a dose-dependent manner through several mechanisms. These mechanisms included inhibition of secretion and phosphorylation of several mediators involved in the cellular degranulation signaling pathways: Concentrations up to 10 mmol/L inhibited the secretion of β-hexosaminidase by up to 59.4% and significantly reduced the activating phosphorylation of PLCγ1, PI3K, and Akt. In addition, the formation of microtubules, which are crucial for the intracellular movement of granules and their fusion with the cell membrane to enable granule release or degranulation, was hampered [145]. 6.8. Other Adverse Effects No other adverse effects of trigonelline have been documented. Go to: 7. Regulatory Information No limit values, such as tolerable or acceptable daily intake levels, have been derived for trigonelline. Therefore, to our knowledge, no specific regulations are currently in force in the EU or other parts of the world. Go to: 8. Risk Assessment 8.1. Limitations As studies on the bioactivity of trigonelline have focused on beneficial health effects, toxicological data are scarce. There is particularly a shortage of human data, with longitudinal epidemiological and clinical studies altogether lacking. Most of the accessible in vitro studies used supraphysiological doses exceeding the amount of trigonelline that could realistically be ingested through the consumption of coffee and coffee by-products. In vivo studies, on the other hand, are often characterized by mechanistic limitations [55] and cannot be extrapolated to human scale without uncertainty due to interspecies differences. Furthermore, the exposure estimates made in the present work are specifically rather vague for coffee by-products, as little is known about the trigonelline content and level of consumption of these matrices. 8.2. Acute Oral Exposure of Trigonelline The only toxicological threshold experimentally established to date for acute oral exposure to trigonelline that can be used in a risk assessment is the oral LD50 of 5000 mg/kg bw derived from rat studies. Using the method of Gold et al. [146], the LD50 values were extrapolated to the lower one-sided confidence limit of the benchmark dose (BMDL)10 values, assuming linear behavior (as no other information on dose-response is available), to obtain a more conservative toxicological threshold (see also Lachenmeier and Rehm [147] for remarks on extrapolation when only LD50 values are available for risk assessment). For an average person weighing 70 kg, the extrapolated BMDL10 corresponds to an intake of 34.3 g of trigonelline per day. Thus, an average person would have to consume 4.8 L of coffee beverages (Table 5), the matrix shown to contribute most to the acute exposure (see Table 3), in a single day to reach this value. This level of consumption is deemed unrealistic as it exceeds the maximum daily coffee consumption reported for member states of the EU (see Table 3) by factor 2.5 and is beyond any volume of coffee beverages that can rationally be expected to be consumed by a person throughout one day. Therefore, no toxic or adverse effects upon acute oral exposure to trigonelline through consumption of coffee beverages are to be expected. Table 5 Estimated beverage volume (L) for reaching oral BMDL10 of 490 mg/kg bw of trigonelline. Matrix Beverage Volume (L) per Day for Reaching Oral BMDL10 = 490 mg/kg bw 1 Leaves 293 Flowers 55 Cherry husks/pulp 635 Green coffee beans 100 Silver skin 94 Coffee beverages 4.8 Open in a separate window 1 For explanation on assumed preparation of servings considered in the calculations, see Section 3.2. An estimate of BMDL10 is obtained from LD50 (5000 mg/kg bw) by division by 10.2 using Method B of Gold et al. [146]. Since tea infusions prepared from coffee by-products contain significantly lower levels of trigonelline than coffee beverages (Table 5), as estimated in the assumed worst-case scenario, harmful effects are less likely to occur after acute oral exposure from these matrices, as the corresponding volume of beverage that would need to be consumed over the course of a day to meet the BMDL10 is completely unrealistic. 8.3. Chronic Oral Exposure of Trigonelline Individuals habitually consuming coffee beverages and/or coffee by-products daily are chronically exposed to trigonelline. As presented in Section 4, repeated ingestion of coffee beverages led to an accumulation of trigonelline in human plasma and to markedly elevated plasma levels, which, on the premise of continued regular coffee consumption, are unlikely to be completely cleared due to the long biological half-life of trigonelline. Considering its low octanol-water partition coefficient and volume of distribution, on the other hand, trigonelline is not expected to accumulate in human body tissues. In fact, no trigonelline-induced toxic effects have been observed in animals or humans in studies on reproductive toxicity, teratogenic effects, neurotoxicity, immunogenicity, and allergenicity. Taking into account the limitations mentioned in Section 8.1 and the ambiguous results of the genotoxicity and mutagenicity studies, the current data do not allow for a reasonable, soundly substantiated risk assessment for chronic oral exposure to trigonelline. Additional studies on potential toxic effects are needed because the current toxicological database is insufficient. Additionally, further efforts are recommended to address open questions, such as the trigonelline-mediated aggravation of osteoporotic skeletal changes shown in a subchronic toxicity study in estrogen-deficient rats. No other study on this subject was found, and it is unclear whether humans diagnosed with estrogen deficiency or related conditions may experience similar unfavorable effects from chronic oral exposure to trigonelline. For a comprehensive risk assessment, the presence of trigonelline in other dietary or food sources and their role in human oral exposure must also be considered. On the other hand, the EFSA has evaluated the safety of several trigonelline-containing coffee by-products as an obligatory step in the authorization process of novel foods and traditional foods from a third country in the EU. In all cases, no safety concerns were raised [144,148,149]. Furthermore, coffee consumption is characterized by a long history, having been consumed in Europe since the 17th century [53]. Despite this long history, no reports of toxic effects attributed to trigonelline are known. In this respect, trigonelline appears to be rather safe in concentrations ingested via coffee and coffee by-products, which would also question the priority of this compound for further toxicological studies. Go to: 9. Conclusions In this review, oral exposure to trigonelline from coffee and coffee by-products was assessed for health-related risks based on current pharmacokinetic and toxicological knowledge and available consumption data for the EU general population. No signs of adverse effects following acute exposure were identified. However, due to the scarcity of toxicological data and the lack of epidemiological and clinical studies, it is not possible to draw a well-founded conclusion on the safety of chronic exposure to trigonelline orally ingested from the concerning matrices. The current state of knowledge, however, suggests that chronic exposure to trigonelline in contents typical for coffee and coffee by-products may also be unproblematic in terms of human health. Go to: Acknowledgments This review article was published as part of the Postgraduate Study Program “Toxicology and Environmental Protection” at Leipzig University in Leipzig, Germany. Go to: Funding Statement This research received no external funding. Go to: Author Contributions Conceptualization, N.K. and D.W.L.; methodology, N.K.; software, N.K.; validation, N.K. and D.W.L.; formal analysis, N.K.; investigation, N.K.; resources, D.W.L. and H.F.; data curation, N.K.; writing—original draft preparation, N.K.; writing—review and editing, D.W.L., H.F., S.S. and N.K.; visualization, N.K.; supervision, D.W.L.; project administration, D.W.L. All authors have read and agreed to the published version of the manuscript. Go to: Institutional Review Board Statement Not applicable. Go to: Informed Consent Statement Not applicable. Go to: Data Availability Statement No new data were created or analyzed in this study. Data sharing is not applicable to this article. Go to: Conflicts of Interest S.S. is the owner of Coffee Consulate, Mannheim, Germany. Coffee Consulate is an independent training and research center. Coffee Consulate is currently researching the potential of coffee by-products. However, S.S. reports that there is no conflict of interest related to the work under consideration. The other authors declare that they have no conflicts of interest. Go to: Footnotes Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. Go to: References 1. Jahns E. Ueber die Alkaloïde des Bockshornsamens. Ber. Dtsch. Chem. Ges. 1885;18:2518–2523. doi: 10.1002/cber.188501802144. [CrossRef] [Google Scholar] 2. National Center for Biotechnology Information PubChem Compound Summary for CID 5570, Trigonelline. [(accessed on 25 September 2022)]; Available online: https://pubchem.ncbi.nlm.nih.gov/compound/5570#section=Names-and-Identifiers 3. CAS Common Chemistry CAS, a Division of the American Chemical Society. Trigonelline. [(accessed on 25 September 2022)]. Available online: https://commonchemistry.cas.org/detail?cas_rn=535-83-1 4. Mazzafera P. Trigonelline in coffee. Phytochemistry. 1991;30:2309–2310. doi: 10.1016/0031-9422(91)83637-Z. [CrossRef] [Google Scholar] 5. Viani R., Horman I. Thermal Behavior of Trigonelline. J. Food Sci. 1974;39:1216–1217. doi: 10.1111/j.1365-2621.1974.tb07357.x. [CrossRef] [Google Scholar] 6. Cangussu L.B., Melo J.C., Franca A.S., Oliveira L.S. Chemical Characterization of Coffee Husks, a By-Product of Coffea arabica Production. Foods. 2021;10:3125. doi: 10.3390/foods10123125. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 7. Wu X., Skog K., Jägerstad M. Trigonelline, a naturally occurring constituent of green coffee beans behind the mutagenic activity of roasted coffee? Mutat. Res. Genet. Toxicol. Environ. Mutagen. 1997;391:171–177. doi: 10.1016/S1383-5718(97)00065-X. [PubMed] [CrossRef] [Google Scholar] 8. Ashihara H. Metabolism of alkaloids in coffee plants. Braz. J. Plant Physiol. 2006;18:1–8. doi: 10.1590/S1677-04202006000100001. [CrossRef] [Google Scholar] 9. Zheng X., Ashihara H. Distribution, Biosynthesis and Function of Purine and Pyridine Alkaloids in Coffea arabica Seedlings. Plant Sci. 2004;166:807–813. doi: 10.1016/j.plantsci.2003.11.024. [CrossRef] [Google Scholar] 10. Fung V.A., Cameron T.P., Hughes T.J., Kirby P.E., Dunkel V.C. Mutagenic activity of some coffee flavor ingredients. Mutat. Res. Genet. Toxicol. 1988;204:219–228. doi: 10.1016/0165-1218(88)90092-4. [PubMed] [CrossRef] [Google Scholar] 11. Evans L.S., Tramontano W.A. Trigonelline and promotion of cell arrest in G2 of various legumes. Phytochemistry. 1984;23:1837–1840. doi: 10.1016/S0031-9422(00)84927-4. [CrossRef] [Google Scholar] 12. Mohamadi N., Sharififar F., Pournamdari M., Ansari M. A Review on Biosynthesis, Analytical Techniques, and Pharmacological Activities of Trigonelline as a Plant Alkaloid. J. Diet. Suppl. 2018;15:207–222. doi: 10.1080/19390211.2017.1329244. [PubMed] [CrossRef] [Google Scholar] 13. Matsui A., Yin Y., Yamanaka K., Iwasaki M., Ashihara H. Metabolic fate of nicotinamide in higher plants. Physiol. Plant. 2007;131:191–200. doi: 10.1111/j.1399-3054.2007.00959.x. [PubMed] [CrossRef] [Google Scholar] 14. Taguchi H., Sakaguchi M., Shimabayashi Y. Trigonelline Content in Coffee Beans and the Thermal Conversion of Trigonelline into Nicotinic Acid during the Roasting of Coffee Beans. Agric. Biol. Chem. 1985;49:3467–3471. doi: 10.1080/00021369.1985.10867295. [CrossRef] [Google Scholar] 15. Adepoju A.F., Adenuga O.O., Mapayi E.F., Olaniyi O.O., Adepoju F.A. Coffee: Botany, Distribution, Diversity, Chemical Composition and Its Management. IOSR-JAVS. 2017;10:57–62. doi: 10.9790/2380-1007035762. [CrossRef] [Google Scholar] 16. Ky C.L., Louarn J., Dussert S., Guyot B., Hamon S., Noirot M. Caffeine, Trigonelline, Chlorogenic acids and Sucrose Diversity in Wild Coffea arabica L. and C. canephora P. Accessions. Food Chem. 2001;75:223–230. doi: 10.1016/S0308-8146(01)00204-7. [CrossRef] [Google Scholar] 17. Lang R., Yagar E.F., Eggers R., Hofmann T. Quantitative Investigation of Trigonelline, Nicotinic Acid, and Nicotinamide in Foods, Urine, and Plasma by Means of LC-MS/MS and Stable Isotope Dilution Analysis. J. Agric. Food Chem. 2008;56:11114–11121. doi: 10.1021/jf802838s. [PubMed] [CrossRef] [Google Scholar] 18. Zheng X.-Q., Nagai C., Ashihara H. Pyridine Nucleotide Cycle and Trigonelline (N-Methylnicotinic Acid) Synthesis in Developing Leaves and Fruits of Coffea arabica. Physiol. Plant. 2004;122:404–411. doi: 10.1111/j.1399-3054.2004.00422.x. [CrossRef] [Google Scholar] 19. Acidri R., Sawai Y., Sugimoto Y., Handa T., Sasagawa D., Masunaga T., Yamamoto S., Nishihara E. Phytochemical Profile and Antioxidant Capacity of Coffee Plant Organs Compared to Green and Roasted Coffee Beans. Antioxidants. 2020;9:93. doi: 10.3390/antiox9020093. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 20. Li X., Zhang X., Tan L., Yan H., Yuan Y. Heat-induced formation of N,N-dimethylpiperidinium (mepiquat) in Arabica and Robusta coffee. J. Food Sci. 2020;85:2754–2761. doi: 10.1111/1750-3841.15381. [PubMed] [CrossRef] [Google Scholar] 21. Tice R.R. Trigonelline [535-83-1]: Review of Toxicological Literature, Research Triangle Park, North Carolina 27709, 1997. [(accessed on 16 April 2022)]; Available online: https://ntp.niehs.nih.gov/ntp/htdocs/chem_background/exsumpdf/trigonelline_508.pdf 22. Guertin K.A., Moore S.C., Sampson J.N., Huang W.-Y., Xiao Q., Stolzenberg-Solomon R.Z., Sinha R., Cross A.J. Metabolomics in nutritional epidemiology: Identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am. J. Clin. Nutr. 2014;100:208–217. doi: 10.3945/ajcn.113.078758. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 23. Guertin K.A., Loftfield E., Boca S.M., Sampson J.N., Moore S.C., Xiao Q., Huang W.-Y., Xiong X., Freedman N.D., Cross A.J., et al. Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer. Am. J. Clin. Nutr. 2015;101:1000–1011. doi: 10.3945/ajcn.114.096099. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 24. Playdon M.C., Sampson J.N., Cross A.J., Sinha R., Guertin K.A., Moy K.A., Rothman N., Irwin M.L., Mayne S.T., Stolzenberg-Solomon R., et al. Comparing metabolite profiles of habitual diet in serum and urine. Am. J. Clin. Nutr. 2016;104:776–789. doi: 10.3945/ajcn.116.135301. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 25. Rothwell J.A., Fillâtre Y., Martin J.-F., Lyan B., Pujos-Guillot E., Fezeu L., Hercberg S., Comte B., Galan P., Touvier M., et al. New Biomarkers of Coffee Consumption Identified by the Non-Targeted Metabolomic Profiling of Cohort Study Subjects. PLoS ONE. 2014;9:e93474. doi: 10.1371/journal.pone.0093474. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 26. Lang R., Wahl A., Skurk T., Yagar E.F., Schmiech L., Eggers R., Hauner H., Hofmann T. Development of a Hydrophilic Liquid Interaction Chromatography−High-Performance Liquid Chromatography−Tandem Mass Spectrometry Based Stable Isotope Dilution Analysis and Pharmacokinetic Studies on Bioactive Pyridines in Human Plasma and Urine after Coffee Consumption. Anal. Chem. 2010;82:1486–1497. doi: 10.1021/ac902616k. [PubMed] [CrossRef] [Google Scholar] 27. Joshi J.G., Handler P. Biosynthesis of Trigonelline. J. Biol. Chem. 1960;235:2981–2983. doi: 10.1016/S0021-9258(18)64575-2. [PubMed] [CrossRef] [Google Scholar] 28. Upmeier B., Gross W., Köster S., Barz W. Purification and properties of S-adenosyl-l-methionine:Nicotinic acid-N-methyltransferase from cell suspension cultures of Glycine max L. Arch. Biochem. Biophys. 1988;262:445–454. doi: 10.1016/0003-9861(88)90396-7. [PubMed] [CrossRef] [Google Scholar] 29. Ashihara H., Ludwig I.A., Katahira R., Yokota T., Fujimura T., Crozier A. Trigonelline and related nicotinic acid metabolites: Occurrence, biosynthesis, taxonomic considerations, and their roles in Planta and in human health. Phytochem. Rev. 2015;14:765–798. doi: 10.1007/s11101-014-9375-z. [CrossRef] [Google Scholar] 30. Mizuno K., Matsuzaki M., Kanazawa S., Tokiwano T., Yoshizawa Y., Kato M. Conversion of Nicotinic acid to Trigonelline is Catalyzed by N-methyltransferase Belonged to Motif B′ Methyltransferase Family in Coffea arabica. Biochem. Biophys. Res. Commun. 2014;452:1060–1066. doi: 10.1016/j.bbrc.2014.09.043. [PubMed] [CrossRef] [Google Scholar] 31. Ashihara H. Trigonelline (N-methylnicotinic acid) biosynthesis and its biological role in plants. Nat. Prod. Commun. 2008;3:1934578X0800300906. doi: 10.1177/1934578X0800300906. [CrossRef] [Google Scholar] 32. Ashihara H. Chapter 3—Plant biochemistry: Trigonelline biosynthesis in Coffea arabica and Coffea canephora. In: Preedy V.R., editor. Coffee in Health and Disease Prevention. Academic Press; San Diego, CA, USA: 2015. pp. 19–28. [Google Scholar] 33. Minorsky P.V. The functions of foliar nyctinasty: A review and hypothesis. Biol. Rev. 2019;94:216–229. doi: 10.1111/brv.12444. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 34. Caetano-Anollés G., Gresshoff P.M. Plant Genetic Control of Nodulation. Annu. Rev. Micobiol. 1991;45:345–382. doi: 10.1146/annurev.mi.45.100191.002021. [PubMed] [CrossRef] [Google Scholar] 35. Evans L.S., Almeida M.S., Lynn D.G., Nakanishi K. Chemical characterization of a hormone that promotes cell arrest in g2 in complex tissues. Science. 1979;203:1122–1123. doi: 10.1126/science.203.4385.1122. [PubMed] [CrossRef] [Google Scholar] 36. Minorsky P.V. The hot and the classic: Trigonelline: A diverse regulator in plants. Plant Physiol. 2002;128:7. doi: 10.1104/pp.900014. [CrossRef] [Google Scholar] 37. Barz W. Metabolism and Degradation of Nicotinic Acid in Plant Cell Cultures. In: Neumann K.H., Barz W., Reinhard E., editors. Primary and Secondary Metabolism of Plant Cell Cultures. Springer; Berlin/Heidelberg, Germany: 1985. pp. 186–195. [Google Scholar] 38. Lang R., Dieminger N., Beusch A., Lee Y.-M., Dunkel A., Suess B., Skurk T., Wahl A., Hauner H., Hofmann T. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal. Bioanal. Chem. 2013;405:8487–8503. doi: 10.1007/s00216-013-7288-0. [PubMed] [CrossRef] [Google Scholar] 39. Buffo R.A., Cardelli-Freire C. Coffee flavour: An overview. Flavour. Fragr. J. 2004;19:99–104. doi: 10.1002/ffj.1325. [CrossRef] [Google Scholar] 40. Stadler R.H., Varga N., Hau J., Vera F.A., Welti D.H. Alkylpyridiniums. 1. Formation in Model Systems via Thermal Degradation of Trigonelline. J. Agric. Food Chem. 2002;50:1192–1199. doi: 10.1021/jf011234k. [PubMed] [CrossRef] [Google Scholar] 41. Angelino D., Tassotti M., Brighenti F., Del Rio D., Mena P. Niacin, Alkaloids and (Poly)phenolic Compounds in the Most Widespread Italian Capsule-brewed Coffees. Sci. Rep. 2018;8:17874. doi: 10.1038/s41598-018-36291-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 42. Özçelik B., Kartal M., Orhan I. Cytotoxicity, antiviral and antimicrobial activities of alkaloids, flavonoids, and phenolic acids. Pharm. Biol. 2011;49:396–402. doi: 10.3109/13880209.2010.519390. [PubMed] [CrossRef] [Google Scholar] 43. Bhandarkar N.S., Mouatt P., Majzoub M.E., Thomas T., Brown L., Panchal S.K. Coffee pulp, a by-product of coffee production, modulates gut microbiota and improves metabolic syndrome in high-carbohydrate, high-fat diet-fed rats. Pathogens. 2021;10:1369. doi: 10.3390/pathogens10111369. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 44. de Abreu Pinheiro F., Ferreira Elias L., de Jesus Filho M., Uliana Modolo M., de Cássia Gomes Rocha J., Fumiere Lemos M., Scherer R., Soares Cardoso W. Arabica and Conilon Coffee Flowers: Bioactive Compounds and Antioxidant Capacity under Different Processes. Food Chem. 2021;336:127701. doi: 10.1016/j.foodchem.2020.127701. [PubMed] [CrossRef] [Google Scholar] 45. Nazir Lone A., Tanveer Malik A., Shahid Naikoo H., Sharma Raghu R., Sheikh A. Tasduq. Trigonelline, a naturally occurring alkaloidal agent protects ultraviolet-B (UV-B) irradiation induced apoptotic cell death in human skin fibroblasts via attenuation of oxidative stress, restoration of cellular calcium homeostasis and prevention of endoplasmic reticulum (ER) stress. J. Photochem. Photobiol. B Biol. 2020;202:111720. doi: 10.1016/j.jphotobiol.2019.111720. [PubMed] [CrossRef] [Google Scholar] 46. Aldakinah A.-A.A., Al-Shorbagy M.Y., Abdallah D.M., El-Abhar H.S. Trigonelline and Vildagliptin Antidiabetic Effect: Improvement of Insulin Signalling Pathway. J. Pharm. Pharmacol. 2017;69:856–864. doi: 10.1111/jphp.12713. [PubMed] [CrossRef] [Google Scholar] 47. Choi M., Mukherjee S., Yun J.W. Trigonelline Induces Browning in 3T3-L1 White Adipocytes. Phytother. Res. 2021;35:1113–1124. doi: 10.1002/ptr.6892. [PubMed] [CrossRef] [Google Scholar] 48. Mishkinsky J., Joseph B., Sulman F.G., Goldschmied A.L. Hypoglycaemic effect of trigonelline. Lancet. 1967;290:1311–1312. doi: 10.1016/S0140-6736(67)90428-X. [PubMed] [CrossRef] [Google Scholar] 49. van Dijk A.E., Olthof M.R., Meeuse J.C., Seebus E., Heine R.J., van Dam R.M. Acute Effects of Decaffeinated Coffee and the Major Coffee Components Chlorogenic Acid and Trigonelline on Glucose Tolerance. Diabetes Care. 2009;32:1023–1025. doi: 10.2337/dc09-0207. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 50. Tharaheswari M., Jayachandra Reddy N., Kumar R., Varshney K.C., Kannan M., Sudha Rani S. Trigonelline and diosgenin attenuate ER stress, oxidative stress-mediated damage in pancreas and enhance adipose tissue PPARγ activity in type 2 diabetic rats. Mol. Cell Biochem. 2014;396:161–174. doi: 10.1007/s11010-014-2152-x. [PubMed] [CrossRef] [Google Scholar] 51. Peerapen P., Boonmark W., Thongboonkerd V. Trigonelline prevents kidney stone formation processes by inhibiting calcium oxalate crystallization, growth and crystal-cell adhesion, and downregulating crystal receptors. Biomed. Pharmacother. 2022;149:112876. doi: 10.1016/j.biopha.2022.112876. [PubMed] [CrossRef] [Google Scholar] 52. Socała K., Szopa A., Serefko A., Poleszak E., Wlaź P. Neuroprotective Effects of Coffee Bioactive Compounds: A Review. Int. J. Mol. Sci. 2021;22:107. doi: 10.3390/ijms22010107. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 53. Teketay D. History, Botany and Ecological Requirements of Coffee. Walia. 1999;20:28–50. [Google Scholar] 54. Petracco M. Our Everyday Cup of Coffee: The Chemistry behind Its Magic. J. Chem. Educ. 2005;82:1161. doi: 10.1021/ed082p1161. [CrossRef] [Google Scholar] 55. Romualdo G.R., Rocha A.B., Vinken M., Cogliati B., Moreno F.S., García Chaves M.A., Barbisan L.F. Drinking for protection? Epidemiological and experimental evidence on the beneficial effects of coffee or major coffee compounds against gastrointestinal and liver carcinogenesis. Food Res. Int. 2019;123:567–589. doi: 10.1016/j.foodres.2019.05.029. [PubMed] [CrossRef] [Google Scholar] 56. United States Department of Agriculture (USDA) Foreign Agricultural Service Coffee: World Markets and Trade—December 2022. [(accessed on 1 January 2023)];2022 Available online: https://apps.fas.usda.gov/psdonline/circulars/coffee.pdf 57. United States Department of Agriculture (USDA) Foreign Agricultural Service Coffee: World Markets and Trade—December 2018. 2018. [(accessed on 4 January 2023)]. Available online: https://downloads.usda.library.cornell.edu/usda-esmis/files/m900nt40f/41687n67f/nk322j622/coffee.pdf 58. United States Department of Agriculture (USDA) Foreign Agricultural Service Coffee: World Markets and Trade—December 2016. 2016. [(accessed on 4 January 2023)]. Available online: https://downloads.usda.library.cornell.edu/usda-esmis/files/m900nt40f/vq27zn848/fq977v30w/tropprod-12-16-2016.pdf 59. International Coffee Organization 2021 Coffee Development Report: The Future of Coffee: Investing in Youth for a Resilient and Sustainable Coffee Sector. 2021. [(accessed on 9 January 2023)]. Available online: https://www.internationalcoffeecouncil.com/_files/ugd/0dd08e_b2c2768ae87045e383962ce14ef44925.pdf 60. Lachenmeier D.W., Teipel J., Scharinger A., Kuballa T., Walch S.G., Grosch F., Bunzel M., Okaru A.O., Schwarz S. Fully Automated Identification of Coffee Species and Simultaneous Quantification of Furfuryl Alcohol Using NMR Spectroscopy. J. AOAC Int. 2020;103:306–314. doi: 10.1093/jaocint/qsz020. [PubMed] [CrossRef] [Google Scholar] 61. Krishnan S. Sustainable Coffee Production. Oxf. Res. Encycl. 2017;17:1–34. doi: 10.1093/acrefore/9780199389414.013.224. [CrossRef] [Google Scholar] 62. Klingel T., Kremer J.I., Gottstein V., Rajcic de Rezende T., Schwarz S., Lachenmeier D.W. A Review of Coffee By-Products Including Leaf, Flower, Cherry, Husk, Silver Skin, and Spent Grounds as Novel Foods within the European Union. Foods. 2020;9:665. doi: 10.3390/foods9050665. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 63. de Melo Pereira G.V., de Carvalho Neto D.P., Magalhães Júnior A.I., Vásquez Z.S., Medeiros A.B.P., Vandenberghe L.P.S., Soccol C.R. Exploring the impacts of postharvest processing on the aroma formation of coffee beans—A review. Food Chem. 2019;272:441–452. doi: 10.1016/j.foodchem.2018.08.061. [PubMed] [CrossRef] [Google Scholar] 64. Lachenmeier D.W., Schwarz S., Rieke-Zapp J., Cantergiani E., Rawel H., Martín-Cabrejas M.A., Martuscelli M., Gottstein V., Angeloni S. Coffee By-Products as Sustainable Novel Foods: Report of the 2nd International Electronic Conference on Foods—“Future Foods and Food Technologies for a Sustainable World” Foods. 2022;11:3. doi: 10.3390/foods11010003. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 65. Lachenmeier D.W., Rajcic de Rezende T., Schwarz S. An Update on Sustainable Valorization of Coffee By-Products as Novel Foods within the European Union. Biol. Life Sci. Forum. 2021;6:37. doi: 10.3390/Foods2021-10969. [CrossRef] [Google Scholar] 66. Hoseini M., Cocco S., Casucci C., Cardelli V., Corti G. Coffee By-products Derived Resources. A Review. Biomass Bioenergy. 2021;148:106009. doi: 10.1016/j.biombioe.2021.106009. [CrossRef] [Google Scholar] 67. Murthy P.S., Naidu M.M. Sustainable management of coffee industry by-products and value addition—A review. Resour. Conserv. Recycl. 2012;66:45–58. doi: 10.1016/j.resconrec.2012.06.005. [CrossRef] [Google Scholar] 68. Murthy P.S., Naidu M.M. Recovery of Phenolic Antioxidants and Functional Compounds from Coffee Industry By-Products. Food Bioprocess Technol. 2012;5:897–903. doi: 10.1007/s11947-010-0363-z. [CrossRef] [Google Scholar] 69. Benitez V., Rebollo-Hernanz M., Hernanz S., Chantres S., Aguilera Y., Martin-Cabrejas M.A. Coffee parchment as a new dietary fiber ingredient: Functional and physiological characterization. Food Res. Int. 2019;122:105–113. doi: 10.1016/j.foodres.2019.04.002. [PubMed] [CrossRef] [Google Scholar] 70. Martuscelli M., Esposito L., Di Mattia C.D., Ricci A., Mastrocola D. Characterization of Coffee Silver Skin as Potential Food-Safe Ingredient. Foods. 2021;10:1367. doi: 10.3390/foods10061367. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 71. Tores de la Cruz S., Iriondo-DeHond A., Herrera T., Lopez-Tofiño Y., Galvez-Robleño C., Prodanov M., Velazquez-Escobar F., Abalo R., Del Castillo M.D. An Assessment of the Bioactivity of Coffee Silverskin Melanoidins. Foods. 2019;8:68. doi: 10.3390/foods8020068. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 72. European Parliament and Council of the European Union Regulation (EU) 2015/2283 of the European Parliament and of the Council of 25 November 2015 on novel foods, amending Regulation (EU) No 1169/2011 of the European Parliament and of the Council and repealing Regulation (EC) No 258/97 of the European Parliament and of the Council and Commission Regulation (EC) No 1852/2001. Off. J. Eur. Union. 2015;L 327:1–21. [Google Scholar] 73. European Commission Commission Implementing Regulation (EU) 2017/2470 of 20 December 2017 Establishing the Union List of Novel Foods in Accordance with Regulation (EU) 2015/2283 of the European Parliament and of the Council on Novel Foods. Off. J. Eur. Union. 2017;L 351:72–201. [Google Scholar] 74. Stennert A., Maier H.G. Trigonelline in coffee. Z. Lebensm. Unters. Forsch. 1994;199:198–200. doi: 10.1007/BF01193443. [PubMed] [CrossRef] [Google Scholar] 75. Wang X., Hong D.-F., Hu G.-L., Li Z.-R., Peng X.-R., Shi Q.-Q., Qiu M.-H. Morphological Changes and Component Characterization of Coffee Silverskin. Molecules. 2021;26:4914. doi: 10.3390/molecules26164914. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 76. Monteiro Â., Colomban S., Azinheira H.G., Guerra-Guimarães L., Do Céu Silva M., Navarini L., Resmini M. Dietary Antioxidants in Coffee Leaves: Impact of Botanical Origin and Maturity on Chlorogenic Acids and Xanthones. Antioxidants. 2019;9:6. doi: 10.3390/antiox9010006. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 77. Chen X., Ma Z., Kitts D.D. Effects of Processing Method and Age of Leaves on Phytochemical Profiles and Bioactivity of Coffee Leaves. Food Chem. 2018;249:143–153. doi: 10.1016/j.foodchem.2017.12.073. [PubMed] [CrossRef] [Google Scholar] 78. Cangeloni L., Bonechi C., Leone G., Consumi M., Andreassi M., Magnani A., Rossi C., Tamasi G. Characterization of Extracts of Coffee Leaves (Coffea arabica L.) by Spectroscopic and Chromatographic/Spectrometric Techniques. Foods. 2022;11:2495. doi: 10.3390/foods11162495. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 79. Montis A., Souard F., Delporte C., Stoffelen P., Stévigny C., van Antwerpen P. Coffee Leaves: An Upcoming Novel Food? Planta Med. 2021;87:949–963. [PubMed] [Google Scholar] 80. Nguyen T., Cho E.J., Song Y., Oh C.H., Funada R., Bae H.-B. Use of coffee flower as a novel resource for the production of bioactive compounds, melanoidins, and bio-sugars. Food Chem. 2019;299:125120. doi: 10.1016/j.foodchem.2019.125120. [PubMed] [CrossRef] [Google Scholar] 81. Wirz K., Schwarz S., Richling E., Walch S.G., Lachenmeier D.W. Coffee Flower as a Promising Novel Food—Chemical Characterization and Sensory Evaluation. Biol. Life Sci. Forum. 2022;18:53. doi: 10.3390/Foods2022-12967. [CrossRef] [Google Scholar] 82. Castaldo L., Graziani G., Gaspari A., Izzo L., Luz C., Mañes J., Rubino M., Meca G., Ritieni A. Study of the chemical components, bioactivity and antifungal properties of the coffee husk. J. Food. Res. 2018;7:43–54. doi: 10.5539/jfr.v7n4p43. [CrossRef] [Google Scholar] 83. Koskei R.K., Mugendi B., Muliro P. Effects of processing methods on fatty acid profiles and biochemical compounds of Arabica coffee cultivars. Afr. J. Food Sci. 2020;14:92–97. [Google Scholar] 84. Mehari B., Redi-Abshiro M., Chandravanshi B.S., Atlabachew M., Combrinck S., McCrindle R. Simultaneous Determination of Alkaloids in Green Coffee Beans from Ethiopia: Chemometric Evaluation of Geographical Origin. Food Anal. Methods. 2016;9:1627–1637. doi: 10.1007/s12161-015-0340-2. [CrossRef] [Google Scholar] 85. Casal S., Oliveira M.B.P.P., Alves M.R., Ferreira M.A. Discriminate Analysis of Roasted Coffee Varieties for Trigonelline, Nicotinic Acid, and Caffeine Content. J. Agric. Food Chem. 2000;48:3420–3424. doi: 10.1021/jf990702b. [PubMed] [CrossRef] [Google Scholar] 86. Choi B., Koh E. Spent coffee as a rich source of antioxidative compounds. Food Sci. Biotechnol. 2017;26:921–927. doi: 10.1007/s10068-017-0144-9. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 87. Caprioli G., Cortese M., Maggi F., Minnetti C., Odello L., Sagratini G., Vittori S. Quantification of caffeine, trigonelline and nicotinic acid in espresso coffee: The influence of espresso machines and coffee cultivars. Int. J. Food. Sci. Nutr. 2014;65:465–469. doi: 10.3109/09637486.2013.873890. [PubMed] [CrossRef] [Google Scholar] 88. Heo J., Adhikari K., Choi K.S., Lee J. Analysis of Caffeine, Chlorogenic Acid, Trigonelline, and Volatile Compounds in Cold Brew Coffee Using High-Performance Liquid Chromatography and Solid-Phase Microextraction—Gas Chromatography-Mass Spectrometry. Foods. 2020;9:1746. doi: 10.3390/foods9121746. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 89. Zhang J., Sun X., Liu P., Zhang T., Jelderks J.A., Corke H. Preliminary Characterization of Phytochemicals and Polysaccharides in Diverse Coffee Cascara Samples: Identification, Quantification and Discovery of Novel Compounds. Foods. 2022;11:1710. doi: 10.3390/foods11121710. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 90. Wu H., Gu J., Amrit B.K., Nawaz M.A., Barrow C.J., Dunshea F., Suleria H. Effect of processing on bioaccessibility and bioavailability of bioactive compounds in coffee beans. Food Biosci. 2022;46:101373. doi: 10.1016/j.fbio.2021.101373. [CrossRef] [Google Scholar] 91. Stadler R.H., Varga N., Milo C., Schilter B., Vera F.A., Welti D.H. Alkylpyridiniums. 2. Isolation and Quantification in Roasted and Ground Coffees. J. Agric. Food Chem. 2002;50:1200–1206. doi: 10.1021/jf011235c. [PubMed] [CrossRef] [Google Scholar] 92. Lang R., Yagar E.F., Wahl A., Beusch A., Dunkel A., Dieminger N., Eggers R., Bytof G., Stiebitz H., Lantz I., et al. Quantitative Studies on Roast Kinetics for Bioactives in Coffee. J. Agric. Food Chem. 2013;61:12123–12128. doi: 10.1021/jf403846g. [PubMed] [CrossRef] [Google Scholar] 93. Ziefuß A.R., Hupfeld T., Meckelmann S.W., Meyer M., Schmitz O.J., Kaziur-Cegla W., Tintrop L.K., Schmidt T.C., Gökce B., Barcikowski S. Ultrafast cold-brewing of coffee by picosecond-pulsed laser extraction. NPJ Sci. Food. 2022;6:19. doi: 10.1038/s41538-022-00134-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 94. Steger M.C., Rigling M., Blumenthal P., Segatz V., Quintanilla-Belucci A., Beisel J.M., Rieke-Zapp J., Schwarz S., Lachenmeier D.W., Zhang Y. Coffee Leaf Tea from El Salvador: On-Site Production Considering Influences of Processing on Chemical Composition. Foods. 2022;11:2553. doi: 10.3390/foods11172553. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 95. Arai K., Terashima H., Aizawa S., Taga A., Yamamoto A., Tsutsumiuchi K., Kodama S. Simultaneous determination of trigonelline, caffeine, chlorogenic acid and their related compounds in instant coffee samples by HPLC using an acidic mobile phase Containing Octanesulfonate. Anal. Sci. 2015;31:831–835. doi: 10.2116/analsci.31.831. [PubMed] [CrossRef] [Google Scholar] 96. Jeszka-Skowron M., Frankowski R., Zgoła-Grześkowiak A. Comparison of methylxantines, trigonelline, nicotinic acid and nicotinamide contents in brews of green and processed Arabica and Robusta coffee beans—Influence of steaming, decaffeination and roasting processes on coffee beans. LWT. 2020;125:109344. doi: 10.1016/j.lwt.2020.109344. [CrossRef] [Google Scholar] 97. Teply L.J., Prier R.F. Nutrients in Coffee, Nutritional Evaluation of Coffee Including Niacin Bioassay. J. Agric. Food Chem. 1957;5:375–377. doi: 10.1021/jf60075a010. [CrossRef] [Google Scholar] 98. Honda M., Takezaki D., Tanaka M., Fukaya M., Goto M. Effect of Roasting Degree on Major Coffee Compounds: A Comparative Study between Coffee Beans with and without Supercritical CO2 Decaffeination Treatment. J. Oleo Sci. 2022;71:1541–1550. doi: 10.5650/jos.ess22194. [PubMed] [CrossRef] [Google Scholar] 99. Febvay L., Hamon E., Recht R., Andres N., Vincent M., Aoudé-Werner D., This H. Identification of markers of thermal processing (“roasting”) in aqueous extracts of Coffea arabica L. seeds through NMR fingerprinting and chemometrics. Magn. Reson. Chem. 2019;57:589–602. doi: 10.1002/mrc.4834. [PubMed] [CrossRef] [Google Scholar] 100. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Drinking coffee, mate, and very hot beverages. IARC Monogr. Eval. Carcinog. Risks Hum. 2018;116:1–501. [Google Scholar] 101. European Commission Commission Implementing Regulation (EU) 2020/917 of 1 July 2020 Authorising the Placing on the Market of Infusion from Coffee leaves of Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner as a Traditional Food from a Third Country under Regulation (EU) 2015/2283 of the European Parliament and of the Council and Amending Implementing Regulation (EU) 2017/2470. Off. J. Eur. Union. 2020;L 209:10–13. [Google Scholar] 102. Max Rubner-Institut . Nationale Verzehrsstudie II: Ergebnisberich, Teil 1. Max Rubner-Institut; Karlsruhe, Germany: 2008. [(accessed on 11 January 2023)]. Available online: https://www.bmel.de/SharedDocs/Downloads/DE/_Ernaehrung/NVS_Ergebnisbericht.pdf?__blob=publicationFile&v=2 [Google Scholar] 103. Max Rubner-Institut . Nationale Verzehrsstudie II: Ergebnisbericht, Teil 2. Max Rubner-Institut; Karlsruhe, Germany: 2008. [(accessed on 11 January 2023)]. Available online: https://www.bmel.de/SharedDocs/Downloads/DE/_Ernaehrung/NVS_ErgebnisberichtTeil2.pdf?__blob=publicationFile&v=2 [Google Scholar] 104. Yuyama S., Suzuki T. The Excretion of N1-Methyl-2-Pyridone-5-Carboxylic Acid and Related Compounds in Human Subjects after Oral Administration of Nicotinic Acid, Trigonalline and N1-Methyl-2-Pyridone-5-Carboxylic Acid. In: Schwarcz R., Young S.N., Brown R.R., editors. Kynurenine and Serotonin Pathways: Progress in Tryptophan Research. Springer; Boston, MA, USA: 1991. pp. 475–479. [PubMed] [Google Scholar] 105. Yuyama S., Kawano Y. Urinary Excretion of N1-Menthyl-2-Pyridone-5-Carboxylic Acid and the Fate of Remaining of Trigonelline. In: Filippini G.A., Costa C.V.L., Bertazzo A., editors. Recent Advances in Tryptophan Research: Tryptophan and Serotonin Pathways. Springer US; Boston, MA, USA: 1996. pp. 599–604. [PubMed] [Google Scholar] 106. Lang R., Wahl A., Stark T., Hofmann T. Urinary N-methylpyridinium and trigonelline as candidate dietary biomarkers of coffee consumption. Mol. Nutr. Food. Res. 2011;55:1613–1623. doi: 10.1002/mnfr.201000656. [PubMed] [CrossRef] [Google Scholar] 107. Midttun Ø., Ulvik A., Nygård O., Ueland P.M. Performance of Plasma Trigonelline as a Marker of Coffee Consumption in an Epidemiologic Setting. Am. J. Clin. Nutr. 2018;107:941–947. doi: 10.1093/ajcn/nqy059. [PubMed] [CrossRef] [Google Scholar] 108. Bresciani L., Tassotti M., Rosi A., Martini D., Antonini M., Dei Cas A., Bonadonna R., Brighenti F., Del Rio D., Mena P. Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study. Mol. Nutr. Food. Res. 2020;64:2000489. doi: 10.1002/mnfr.202000489. [PubMed] [CrossRef] [Google Scholar] 109. Cheng Z.J., Wu J.J., Liu Z.Q., Lin N. Development of a hydrophilic interaction chromatography-UPLC assay to determine trigonelline in rat plasma and its application in a pharmacokinetic study. Chin. J. Nat. Med. 2013;11:164–170. doi: 10.3724/SP.J.1009.2013.00164. [PubMed] [CrossRef] [Google Scholar] 110. Holford N., Yim D.-S. Volume of Distribution. Transl. Clin. Pharmacol. 2016;24:74–77. doi: 10.12793/tcp.2016.24.2.74. [CrossRef] [Google Scholar] 111. Farid M.M., Yang X., Kuboyama T., Tohda C. Trigonelline recovers memory function in Alzheimer’s disease model mice: Evidence of brain penetration and target molecule. Sci. Rep. 2020;10:16424. doi: 10.1038/s41598-020-73514-1. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 112. Lindenblad G.E., Kaihara M., Price J.M. The occurrence of N-methyl-2-pyridone-5-carboxylic acid and its glycine conjugate in normal human urine. J. Biol. Chem. 1956;219:893–901. doi: 10.1016/S0021-9258(18)65747-3. [PubMed] [CrossRef] [Google Scholar] 113. Strohm D., Bechthold A., Isik N., Leschik-Bonnet E., Heseker. H. Revised reference values for the intake of thiamin (vitamin B1), riboflavin (vitamin B2), and niacin. NFS J. 2016;3:20–24. doi: 10.1016/j.nfs.2016.02.003. [CrossRef] [Google Scholar] 114. Tohda C., Nakamura N., Komatsu K., Hattori M. Trigonelline-Induced Neurite Outgrowth in Human Neuroblastoma SK-N-SH Cells. Biol. Pharm. Bull. 1999;22:679–682. doi: 10.1248/bpb.22.679. [PubMed] [CrossRef] [Google Scholar] 115. Liao J.C., Lee K.T., You B.J., Lee C.L., Chang W.T., Wu Y.C., Lee H.-Z. Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration. Food Nutr. Res. 2015;59:29884. doi: 10.3402/fnr.v59.29884. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 116. Brazda F.G., Coulson R.A. Toxicity of Nicotinic Acid and Some of Its Derivatives. Proc. Soc. Exp. Biol. Med. 1946;62:19–20. doi: 10.3181/00379727-62-15356. [PubMed] [CrossRef] [Google Scholar] 117. Mishkinsky J.S., Goldschmied A., Joseph B., Ahronson Z., Sulman F.G. Hypoglycaemic effect of Trigonella foenum graecum and Lupinus termis (leguminosae) seeds and their major alkaloids in alloxan-diabetic and normal rats. Arch. Int. Pharmacodyn. Ther. 1974;210:27–37. [PubMed] [Google Scholar] 118. Aswar U., Mohan V., Bodhankar S.L. Effect of trigonelline on fertility in female rats. Int. J. Green. Pharm. 2009;3:220. doi: 10.4103/0973-8258.56278. [CrossRef] [Google Scholar] 119. Banerjee P., Eckert A.O., Schrey A.K., Preissner R. ProTox-II: Prediction of Toxicity of Chemicals. [(accessed on 1 March 2023)]. Available online: https://tox-new.charite.de/protox_II/index.php?site=home 120. Banerjee P., Eckert A.O., Schrey A.K., Preissner R. ProTox-II: A webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257–W263. doi: 10.1093/nar/gky318. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 121. Faulkner K.K., Smith J.W.H. Preliminary studies of the toxicity of locoweed extracts. Proc. Oklohoma Acad. Sci. 1950;31:48–50. [Google Scholar] 122. Folwarczna J., Zych M., Nowińska B., Pytlik M., Janas A. Unfavorable effect of trigonelline, an alkaloid present in coffee and fenugreek, on bone mechanical properties in estrogen-deficient rats. Mol. Nutr. Food. Res. 2014;58:1457–1464. doi: 10.1002/mnfr.201300936. [PubMed] [CrossRef] [Google Scholar] 123. Allred K.F., Yackley K.M., Vanamala J., Allred C.D. Trigonelline is a Novel Phytoestrogen in Coffee Beans. J. Nutr. 2009;139:1833–1838. doi: 10.3945/jn.109.108001. [PubMed] [CrossRef] [Google Scholar] 124. Deli T., Orosz M., Jakab A. Hormone Replacement Therapy in Cancer Survivors—Review of the Literature. Pathol. Oncol. Res. 2020;26:63–78. doi: 10.1007/s12253-018-00569-x. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 125. Harding A.T., Heaton N.S. The Impact of Estrogens and Their Receptors on Immunity and Inflammation during Infection. Cancers. 2022;14:909. doi: 10.3390/cancers14040909. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 126. Pirpour Tazehkand A., Salehi R., Velaei K., Samadi N. The potential impact of trigonelline loaded micelles on Nrf2 suppression to overcome oxaliplatin resistance in colon cancer cells. Mol. Biol. Rep. 2020;47:5817–5829. doi: 10.1007/s11033-020-05650-w. [PubMed] [CrossRef] [Google Scholar] 127. Hirakawa N., Okauchi R., Miura Y., Yagasaki K. Anti-Invasive Activity of Niacin and Trigonelline against Cancer Cells. Biosci. Biotechnol. Biochem. 2005;69:653–658. doi: 10.1271/bbb.69.653. [PubMed] [CrossRef] [Google Scholar] 128. Arlt A., Sebens S., Krebs S., Geismann C., Grossmann M., Kruse M.-L., Schreiber S., Schäfer H. Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene. 2013;32:4825–4835. doi: 10.1038/onc.2012.493. [PubMed] [CrossRef] [Google Scholar] 129. Fouzder C., Mukhuty A., Mukherjee S., Malick C., Kundu R. Trigonelline inhibits Nrf2 via EGFR signalling pathway and augments efficacy of Cisplatin and Etoposide in NSCLC cells. Toxicol. In Vitro. 2021;70:105038. doi: 10.1016/j.tiv.2020.105038. [PubMed] [CrossRef] [Google Scholar] 130. Sebens S., Bauer I., Geismann C., Grage-Griebenow E., Ehlers S., Kruse M.-L., Arlt A., Schäfer H. Inflammatory Macrophages Induce Nrf2 Transcription Factor-dependent Proteasome Activity in Colonic NCM460 Cells and Thereby Confer Anti-apoptotic Protection. J. Biol. Chem. 2011;286:40911–40921. doi: 10.1074/jbc.M111.274902. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 131. Chang M.-C., Chen C.-A., Chen P.-J., Chiang Y.-C., Chen Y.-L., Mao T.-L., Lin H.-W., Lin Chiang W.-H., Cheng W.-F. Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways. Biochem. J. 2012;442:293–302. doi: 10.1042/BJ20110282. [PubMed] [CrossRef] [Google Scholar] 132. Tan X., Egami H., Abe M., Nozawa F., Hirota M., Ogawa M. Involvement of MMP-7 in invasion of pancreatic cancer cells through activation of the EGFR mediated MEK–ERK signal transduction pathway. J. Clin. Pathol. 2005;58:1242–1248. doi: 10.1136/jcp.2004.025338. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 133. Nakayama T., Funakoshi-Tago M., Tamura H. Coffee reduces KRAS expression in Caco-2 human colon carcinoma cells via regulation of miRNAs. Oncol. Lett. 2017;14:1109–1114. doi: 10.3892/ol.2017.6227. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 134. Sharma L., Lone N.A., Knott R.M., Hassan A., Abdullah T. Trigonelline prevents high cholesterol and high fat diet induced hepatic lipid accumulation and lipo-toxicity in C57BL/6J mice, via restoration of hepatic autophagy. Food Chem. Toxicol. 2018;121:283–296. doi: 10.1016/j.fct.2018.09.011. [PubMed] [CrossRef] [Google Scholar] 135. Gill E.W., Paton W.D.M., Pertwee R.G. Preliminary Experiments on the Chemistry and Pharmacology of Cannabis. Nature. 1970;228:134–136. doi: 10.1038/228134a0. [PubMed] [CrossRef] [Google Scholar] 136. Tohda C., Kuboyama T., Komatsu K. Search for Natural Products Related to Regeneration of the Neuronal Network. Neurosignals. 2005;14:34–45. doi: 10.1159/000085384. [PubMed] [CrossRef] [Google Scholar] 137. SatheeshKumar N., Mukherjee P.K., Bhadra S., Saha B.P. Acetylcholinesterase enzyme inhibitory potential of standardized extract of Trigonella foenum graecum L and its constituents. Phytomedicine. 2010;17:292–295. doi: 10.1016/j.phymed.2009.06.006. [PubMed] [CrossRef] [Google Scholar] 138. Hossain S.J., Aoshima H., Koda H., Kiso Y. Effects of Coffee Components on the Response of GABAA Receptors Expressed in Xenopus Oocytes. J. Agric. Food Chem. 2003;51:7568–7575. doi: 10.1021/jf0303971. [PubMed] [CrossRef] [Google Scholar] 139. Walker J., Rohm B., Lang R., Pariza M.W., Hofmann T., Somoza V. Identification of coffee components that stimulate dopamine release from pheochromocytoma cells (PC-12) Food Chem. Toxicol. 2012;50:390–398. doi: 10.1016/j.fct.2011.09.041. [PubMed] [CrossRef] [Google Scholar] 140. Lin S.X., Curtis M.A., Sperry J. Pyridine Alkaloids with Activity in the Central Nervous System. Bioorg. Med. Chem. 2020;28:115820. doi: 10.1016/j.bmc.2020.115820. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 141. Ghanem S.S., Fayed H.S., Zhu Q., Lu J.-H., Vaikath N.N., Ponraj J., Mansour S., El-Agnaf O.M.A. Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity. Molecules. 2021;26:3736. doi: 10.3390/molecules26123736. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 142. Fahanik-Babaei J., Baluchnejadmojarad T., Nikbakht F., Roghani M. Trigonelline protects hippocampus against intracerebral Aβ(1–40) as a model of Alzheimer’s disease in the rat: Insights into underlying mechanisms. Metab. Brain Dis. 2019;34:191–201. doi: 10.1007/s11011-018-0338-8. [PubMed] [CrossRef] [Google Scholar] 143. Temraz T.A., Houssen W.E., Jaspars M., Woolley D.R., Wease K.N., Davies S.N., Scott R.H. A pyridinium derivative from Red Sea soft corals inhibited voltage-activated potassium conductances and increased excitability of rat cultured sensory neurones. BMC Pharmacol. 2006;6:10. doi: 10.1186/1471-2210-6-10. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 144. EFSA Panel on Nutrition, Novel Foods. Food Allergens. Turck D., Bohn T., Castenmiller J., de Henauw S., Hirsch-Ernst K.I., Maciuk A., Mangelsdorf I., McArdle H.J., et al. Safety of Dried Coffee husk (Cascara) from Coffea arabica L. as a Novel Food Pursuant to Regulation (EU) 2015/2283. EFSA J. 2022;20:e07085. doi: 10.2903/j.efsa.2022.7085. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 145. Nugrahini A.D., Ishida M., Nakagawa T., Nishi K., Sugahara T. Trigonelline: An alkaloid with anti-degranulation properties. Mol. Immunol. 2020;118:201–209. doi: 10.1016/j.molimm.2019.12.020. [PubMed] [CrossRef] [Google Scholar] 146. Gold L.S., Gaylor D.W., Slone T.H. Comparison of cancer risk estimates based on a variety of risk assessment methodologies. Regul. Toxicol. Pharmacol. 2003;37:45–53. doi: 10.1016/S0273-2300(02)00026-0. [PubMed] [CrossRef] [Google Scholar] 147. Lachenmeier D.W., Rehm J. Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach. Sci. Rep. 2015;5:8126. doi: 10.1038/srep08126. [PMC free article] [PubMed] [CrossRef] [Google Scholar] 148. European Food Safety Authority Technical Report on the notification of cherry pulp from Coffea arabica L. and Coffea canephora Pierre ex A. Froehner as a traditional food from a third country following Article 14 of Regulation (EU) 2015/2283. EFSA Support. Publ. 2021;18:6657E. doi: 10.2903/sp.efsa.2021.EN-6657. [CrossRef] [Google Scholar] 149. European Food Safety Authority Technical Report on the Notification of Infusion from Coffee leaves (Coffea arabica L. and/or Coffea canephora Pierre ex A. Froehner) as a Traditional Food from a Third Country Pursuant to Article 14 of Regulation (EU) 2015/2283. EFSA Support. Publ. 2020;17:1783E. doi: 10.2903/sp.efsa.2020.EN-1783. [CrossRef] [Google Scholar] Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI) OTHER FORMATS PDF (1.3M) ACTIONS Cite Collections SHARE RESOURCES Similar articles Cited by other articles Links to NCBI Databases